# Grünenthal opens $14.5M women's health plant in Peñalolén, Chile

Grünenthal announced the opening of a new women's health products plant in Peñalolén, Chile, with an investment of USD 14.5 million. The facility is the company's center of excellence for hormone production and the most modern in Latin America.

- Type: New facility
- Announced: 2017-01-16
- Where: Peñalolén, Chile
- Value: $14.5M
- Starts operating: 16 Jan 2017
- Status: completed
- Products: women's health hormone products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Grünenthal](https://endata.com/companies/21459.md)

## Sources

- [biospace.com](https://www.biospace.com/grunenthal-release-company-introduces-latin-america-s-most-modern-women-s-health-products-plant), 2017-01-16: "Grünenthal invested USD 14.5 million to build the 1,150 m2 hormone plant, which is the company’s center of excellence for hormone production and the most modern in Latin America."
- [bionity.com](https://www.bionity.com/en/news/161399/gruenenthal-introduces-latin-americas-most-modern-womens-health-products-plant.html), 2017-01-16: "Grünenthal invested USD 14.5 million to build the 1,150 m2 hormone plant, which is the company's center of excellence for hormone production and the most modern in Latin America."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.